LCG
TMCI icon

Lisanti Capital Growth’s Treace Medical Concepts TMCI Stock Holding History

Lisanti Capital Growth’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-252,215
Closed -$2.12M – 146
2025
Q1 		$2.12M Buy
+252,215
New +$2.27M 0.63% 67
2023
Q3 		– Sell
-179,605
Closed -$4.59M – 172
2023
Q2 		$4.59M Buy
+179,605
New +$4.64M 0.64% 68
2023
Q1 		– Sell
-62,405
Closed -$1.43M – 150
2022
Q4 		$1.43M Buy
+62,405
New +$1.44M 0.2% 115

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lisanti Capital Growth's TMCI Position: Q2 2025 in Review

Lisanti Capital Growth sold out of Treace Medical Concepts (TMCI) in Q2 2025, closing a stake of 252,215 shares — an estimated $2.12M sold.

Lisanti Capital Growth first reported a position in TMCI in Q4 2022 and held it in 3 quarters. The position peaked at $4.59M in Q2 2023. 125 funds tracked by Wall St. Rank hold TMCI as of Q2 2025.

  • Lisanti Capital Growth reported no remaining Treace Medical Concepts position as of Q2 2025 after selling out during the quarter.
  • Lisanti Capital Growth sold 252,215 Treace Medical Concepts shares in Q2 2025, an estimated $2.12M.
  • Lisanti Capital Growth first reported a position in Treace Medical Concepts in Q4 2022 and held it in 3 quarters.
  • Lisanti Capital Growth's Treace Medical Concepts position peaked at $4.59M in Q2 2023.
  • 125 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2025.

Based on Lisanti Capital Growth's 13F filing for Q2 2025, filed 7 Aug 2025.